Alpha Tau Medical Ltd (DRTS) Stock Analysis

What Alpha Tau Medical Ltd does

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

Key metrics

ETFs linked to DRTS

Broad-market and Healthcare sector ETFs an investor holding Alpha Tau Medical Ltd is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DRTS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Alpha Tau Medical Ltd?

Alpha Tau Medical Ltd trades under the ticker DRTS on NASDAQ.

Which exchange is DRTS listed on?

DRTS is listed on NASDAQ.

What sector does Alpha Tau Medical Ltd operate in?

Alpha Tau Medical Ltd is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze DRTS in a portfolio?

PortView shows DRTS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.